Completed strategic pivot from R&D focus to commercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned ...

As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists are learning why vaccines can trigger a weaker response in older adults, ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Expanding demand for oligonucleotide therapeutics and GMP-grade reagents drives steady global market expansionAustin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Phosphoramidite Market Size & Growth Analysis ...

A Human Immune Health Atlas, mapping 71 different immune cells and their changes over time, was released to support studies into the aging immune system.

Crispr Therapeutics (CRSP) is downgraded to "Hold" as current valuation already reflects optimism for CTX310 Phase I results and pipeline progress. Intellia Therapeutics (NTLA) maintains a "Buy" ...

Researchers at Washington University School of Medicine in St. Louis have identified central routes that two deadly viruses take to invade human cells and have designed decoy molecules that block the ...

The abrupt termination last month of nearly half a billion dollars in US government contracts for mRNA vaccine research rattled scientists working inside and outside industry. The cuts raised alarm ...

CRISPR powers everything from gene editing to rapid diagnostics, but how did one of its most versatile branches arise? A new Cell study, “Functional RNA splitting drove the evolutionary emergence of ...